Drug intelligence / Profile preview

Xuelian Injection

Development stage
Unknown
Lead developer
Xinjiang Yinduolan Pharmaceutical
Administration
Intravenous, Intramuscular
01

Overview

Xuelian Injection is a traditional Uighur medicine extract derived from *Saussurea involucrata* (Tianshan snow lotus). Developed by Xinjiang Yinduolan Uighur Medicine, it is an injectable herbal product used primarily for the treatment of rheumatoid arthritis and cerebral ischemia-reperfusion injury. The preparation contains active compounds such as chlorogenic acid and rutin. Its pharmacological action is characterized by anti-inflammatory effects, specifically through the inhibition of the Toll-like receptor 4 (TLR4) signaling pathway, which leads to a reduction in inflammatory mediators like TNF-α, IL-1β, and MMP-9. It has been used clinically in China for approximately twenty years and is approved for use in Chinese hospitals.

Brand names
雪莲注射液Xuelian Injection
Other names
Tianshan Snow Lotus InjectionSaussurea Involucrata Injection
02

Targets

MMP9 (Matrix metalloproteinase-9)TLR4 (Toll-like receptor 4)TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Xuelian Injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xuelian Injection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call